Navigation Links
Global Metabolomics Market Reviewed & Forecast in New In-Demand Report Available at MarketPublishers.com
Date:1/17/2013

London, UK (PRWEB) January 17, 2013

In 2012, the world metabolomics market generated about USD 340 million in revenues. The market is predicted to increase at a CARG of nearly 34% to amount to almost USD 1.5 billion by 2018. Growth of the metabolomics market is driven by the ongoing introduction of new biomarker discovery services and the rising demand for toxicity testing. Plant genomics, nutraceuticals, system biology and nutria-genomics segments are likely to have the best growth opportunities in the near future.

Metabolomic Technologies Inc., Metabolon Inc., Metabolomic Discoveries, Waters Corporation, Chenomx Inc., Biocrates Lifesciences, Human Metabolome Technologies, Metanomics, Phenomenome Discoveries Inc., Bruker Corporation, Eisai co. ltd, Beckman Coulter, Nextgen Metabolomics and Agilent Technologies Inc. are amid the behemoths of the worldwide metabolomics market.

New research report “Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017” elaborated by MarketsandMarkets has been recently published by Market Publishers Ltd.

Report Details:

Title: Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017
Published: January, 2013
Pages: 136
Price:    US$ 4,650.00
http://marketpublishers.com/report/life_sciences/healthcare/metabolomics-biomarker-discoverymetabolite-detectionmetabolite-profiling-market-by-applications-drug-discoverytoxicology-assessment-diagnosis.html

The research report thoroughly examines the global metabolomics market and offers future market outlook up to 2017 including forecast of the market size and revenue. The study covers the key market drivers, restraints, opportunities. Furthermore, the study delves into the competitive landscape of the world metabolomics market, reviewing the recent product developments, mergers, acquisitions and collaborations. Profiles of the top market participants and the extensive review of the technology development trends are also available in the research study. In addition, the report provides comprehensive assessment of the investment climate of the industry and points out the most perspective areas for investment.

Reasons to Buy:

  •     The report extends one’s knowledge about the global metabolomics market, helps to understand the current market situation and to evaluate market opportunities.
  •     The report can assist in the planning of market-entry and business expansion strategies by providing understanding of the market trends and key factors driving and shaping the market.
  •     Thorough examination of the competitive pressure in the market, top companies’ profiles and a detailed overview of the recent business activities allow to determine the most successful companies and to choose the perspective partners.
  •     Thorough analysis of the market segments and evaluation of the investment climate help to plan capital investment strategies.
  •     The future forecast allows to trace how the market is set to develop in the years to come.

More new research reports by the publisher can be found at MarketsandMarkets page.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10334334.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Soil Treatment Market Forecast to Grow at a CAGR of 8.5% to 2017 in New Research Report at ReportsnReports.com
2. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
3. Biotechnology: Global Industry Guide
4. WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
5. Lucintel’s Analysis of the Global Glass Mat Thermoplastics Industry: Market is Expected to Reach US $481 Million in 2017
6. Lucintel Performs Competitive Analysis on Top Five Global Consumer Electronic Companies
7. Global Pre-Clinical Imaging Market Analyzed & Forecast by MarketsandMarkets in Report Now Available at MarketPublishers.com
8. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
9. ISPE Announces 2012 Award Winners at Global Annual Meeting
10. Global Agricultural Biotechnology Industry
11. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one ... been named Fellows of the Society this year, the Fellows Committee has announced. ... fields of optics, photonics, and imaging as well as their service to the ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... is has acquired Kendall Research Systems, LLC (KRS) clinical development program. ... develops neural interface technology for research and clinical applications. The terms of the ...
(Date:2/22/2017)... 2017  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Annual Biocom Global Life Science Partnering Conference.  The presentation ... at the Torrey Pines Lodge, in San Diego.  ... Biocom who have chosen our company, amongst numerous others, ... investors, and clinical researchers," said Mr. Chen. "In contrast ...
Breaking Biology Technology:
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
Breaking Biology News(10 mins):